Boothbay Fund Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-36,350
| Closed | -$43K | – | 2372 |
|
|
2022
Q3 | $43K | Sell |
36,350
-18,531
| -34% | -$21.9K | ﹤0.01% | 1842 |
|
|
2022
Q2 | $99K | Sell |
54,881
-41,178
| -43% | -$74.3K | ﹤0.01% | 1724 |
|
|
2022
Q1 | $194K | Sell |
96,059
-15,459
| -14% | -$31.2K | ﹤0.01% | 1513 |
|
|
2021
Q4 | $302K | Hold |
111,518
| – | – | 0.01% | 1097 |
|
|
2021
Q3 | $497K | Sell |
111,518
-16,804
| -13% | -$74.9K | 0.01% | 895 |
|
|
2021
Q2 | $744K | Buy |
128,322
+50,120
| +64% | +$291K | 0.02% | 713 |
|
|
2021
Q1 | $549K | Buy |
78,202
+9,088
| +13% | +$63.8K | 0.02% | 727 |
|
|
2020
Q4 | $332K | Sell |
69,114
-12,284
| -15% | -$59K | 0.01% | 767 |
|
|
2020
Q3 | $475K | Buy |
+81,398
| New | +$475K | 0.03% | 558 |
|
|
2020
Q2 | – | Sell |
-31,100
| Closed | -$198K | – | 1043 |
|
|
2020
Q1 | $198K | Buy |
+31,100
| New | +$198K | 0.02% | 571 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 969 |
|
|
2019
Q3 | – | Sell |
-58,241
| Closed | -$866K | – | 875 |
|
|
2019
Q2 | $866K | Buy |
58,241
+8,188
| +16% | +$122K | 0.08% | 229 |
|
|
2019
Q1 | $1.24M | Buy |
+50,053
| New | +$1.24M | 0.12% | 138 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 875 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 828 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 820 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 775 |
|
|
2017
Q3 | – | Sell |
-2,567
| Closed | -$240K | – | 744 |
|
|
2017
Q2 | $240K | Buy |
+2,567
| New | +$240K | 0.05% | 415 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 908 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 908 |
|